drug
as of 2026-07-01Cognitive Behavior Therapy
Cognitive behavior therapy
at a glance
BEHAVIORAL
Pre-approval / investigational in the US
Developed by Guangzhou Psychiatric Hospital
3 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
BEHAVIORAL
Indications
Trials
3
Trial and Follow-up of the Efficacy of Two-stage Integrated Treatment for Chinese Schizophrenia Inpatients
NCT02850445—Unknown
Cognitive Behavior Therapy for Patients With Psychoses.
NCT03501888—Completed
Cognitive Behavior Therapy and Work Outcome
NCT00810355—Completed
KOLs & investigators
2
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
trial
indication
indication
indication
indication
KOL
Paul Lysaker, PhD
personKOL score —
Helena Fatouros-Bergman, PhD
personKOL score —